Trial Profile
A first in human trial of pnt-ASIT+ in allergic patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2022
Price :
$35
*
At a glance
- Drugs Peanut allergy immunotherapy-ASIT biotech (Primary)
- Indications Peanut hypersensitivity
- Focus Adverse reactions; First in man
- 18 Jun 2018 New trial record